An interventional study of stellate ganglion block with ropivacaine 0.2% 5 mL and stellate ganglion block wit ropivacaine 0.2% 2 mL in Complex Regional Pain Syndromes, sponsored by Maisonneuve-Rosemont Hospital. Withdrawn. Open to participants aged 18 Years to 80 Years. Per ClinicalTrials.gov, last updated 2020-02-24.
Sponsored by Maisonneuve-Rosemont Hospital · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
The purpose of this study is to compare the efficiency and safety of 2ml versus 5ml of local anesthetics used in stellate ganglion blocks for the treatment of complex regional pain syndrome of the arm.
To evaluate if 2ml of 0.2% ropivacaine is less effective in decreasing pain scores by more than 50% when compared to 5ml of 0.2% ropivacaine. To evaluate if 2ml of 0.2% ropivacaine is causes less side effects when compared to 5ml after a stellate ganglion block.
206 studies on the registry are indexed under Complex Regional Pain Syndromes; 54 are open to participants now.
Browse Complex Regional Pain Syndromes studies →Maisonneuve-Rosemont Hospital is the lead sponsor of 73 studies on the registry; 4 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Blood cells that help blood clot. Too few raises the risk of bleeding and bruising. A usual adult range is about 150–400 × 10⁹/L (150,000–400,000 per µL); each lab has its own reference range.
Chronic obstructive pulmonary disease: long-term lung disease that makes it hard to breathe out, including emphysema and chronic bronchitis.
How quickly the kidneys clear creatinine, a waste product, from the blood. A study may estimate it from a blood test with age, weight and sex (often by the Cockcroft–Gault formula), or measure it using blood and urine collected over a set time. Given in mL/min; higher is better.
Contraindication
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Platelets
Blood cells that help blood clot. Too few raises the risk of bleeding and bruising. A usual adult range is about 150–400 × 10⁹/L (150,000–400,000 per µL); each lab has its own reference range.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
COPD
Chronic obstructive pulmonary disease: long-term lung disease that makes it hard to breathe out, including emphysema and chronic bronchitis.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Creatinine clearance (CrCl)
How quickly the kidneys clear creatinine, a waste product, from the blood. A study may estimate it from a blood test with age, weight and sex (often by the Cockcroft–Gault formula), or measure it using blood and urine collected over a set time. Given in mL/min; higher is better.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
stellate ganglion block with ropivacaine 0.2% 5 mL
Procedure: stellate ganglion block with ropivacaine 0.2% 5 mL
stellate ganglion block wit ropivacaine 0.2% 2 mL
Procedure: stellate ganglion block wit ropivacaine 0.2% 2 mL
Each patient will undergo two stellate ganglion blocks and receive both volumes of local anesthetics in random order. The stellate ganglion blocks will be separated by 3 weeks in order to assure that no residual effects from the previous block will influence the results.
Each patient will undergo two stellate ganglion blocks and receive both volumes of local anesthetics in random order. The stellate ganglion blocks will be separated by 3 weeks in order to assure that no residual effects from the previous block will influence the results.
Pain score
Evaluate the efficiency of stellate ganglion block in decreasing pain scores 24 hours after the procedure using a verbal numeric pain rating scale.
Time frame: 24 hours after the stellate ganglion block
Pain score
Evaluate the efficiency of stellate ganglion block in decreasing pain scores 7 days after the procedure using a verbal numeric pain rating scale.
Time frame: 7 days after the stellate ganglion block
Pain score
Evaluate the efficiency of stellate ganglion block in decreasing pain scores 14 days after the procedure using a verbal numeric pain rating scale.
Time frame: 14 days after the stellate ganglion block
Temperature increase in the ipsilateral arm
Evaluate the efficiency of stellate ganglion block on the increase in temperature of the ipsilateral arm using an infrared thermometer. The cutaneous temperature will be measured in order to determine the proportion of patients in each group reaching an increase of \>1.5 C in the ipsilateral arm.
Time frame: 1 hour after the procedure
Horner Syndrome
Evaluate the efficiency of stellate ganglion block to produce an ipsilateral Horner Syndrome as defined by a ptosis and miosis. Evaluate the proportion of patients in each group presenting an ipsilateral Horner syndrome.
Time frame: 1 hour after the procedure
Occurrence of dysphagia after a stellate ganglion block
Patients describing having dysphagia after the stellate ganglion block
Time frame: 1 hour after the procedure
Occurrence of hoarseness after a stellate ganglion block
patients describing having hoarseness after a stellate ganglion block
Time frame: 1 hour after the procedure
Occurrence of foreign body sensation after a stellate ganglion block
patients describing having a foreign body sensation after the stellate ganglion block
Time frame: 1h after the procedure
Occurrence of dyspnea after a stellate ganglion block
patients describing having dyspnea after a stellate ganglion block
Time frame: 1h after the procedure
Occurrence of ipsilateral arm weakness after a stellate ganglion block
patients describing having ipsilateral arm weakness after a stellate ganglion block
Time frame: 1h after the procedure
Occurrence of seizure during a stellate ganglion block
patient having seizure
Time frame: within 30 minutes of performing the stellate ganglion block
Occurrence of hematoma after a stellate ganglion block
physician or patient identifying a neck hematoma
Time frame: During the first 7 days after the procedure
Occurrence of pneumothorax after a stellate ganglion block
physician diagnosing a pneumothorax
Time frame: During the first 7 days after the procedure
No study locations are listed for this record.
Plan to share: No
No publications or documents are linked to this record.
Ran from Oct 2018 to primary completion in Feb 2020, 16 months.
How these figures are worked out, and which studies are left out of them.
This study is withdrawn, as verified in Feb 2020. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Complex Regional Pain Syndromes →
Maisonneuve-Rosemont Hospital